Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomas

Journal of Pathology

Volumn 183, Issue 3, 1997, Pages 281-286

  Pescarmona, Edoardo ^a   De Sanctis, Vitaliana ^b   Pistilli, Alessandra ^b   Pacchiarotti, Alberto ^a   Martelli, Maurizio ^b   Guglielmi, Cesare ^b   Mandelli, Franco ^b   Baroni, Carlo D ^a   Le Coco, Francesco ^b  

^a POLICLINICO UMBERTO I   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bcl 2; Bcl 6; Lymphoma; Oncogenes

Indexed keywords

PROTEIN BCL 2; PROTEIN BCL 6; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE REARRANGEMENT; GERM LINE; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; SOUTHERN BLOTTING;

ADOLESCENT; ADULT; AGED; BLOTTING, SOUTHERN; DISEASE-FREE SURVIVAL; DNA-BINDING PROTEINS; FEMALE; GENE REARRANGEMENT; GENES, BCL-2; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-6; SURVIVAL RATE; TRANSCRIPTION FACTORS; TREATMENT OUTCOME;

EID: 0030694732     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199711)183:3<281::AID-PATH1134>3.0.CO;2-Z     Document Type: Article

References (31)

1. Harris NL, Jaffe ES, Stein H, et al. A Revised European American Classification of Lymphoid Neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
2. Lennert K, Feller A. Histopathology of Non-Hodgkin's Lymphomas. 2nd edn. New York: Springer-Verlag, 1992.
3. Knowles DM (ed.). Neoplastic Hematopathology. Baltimore: Williams & Wilkins, 1992.
4. Ye BH, Lista F, Lo Coco F, et al. Alterations of a zinc finger-encoding gene, Bcl-6, in diffuse large-cell lymphoma. Science 1993; 262: 747-750.
5. Bastard C, Deweindt C, Kerckaert JP, et al. LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype and clinical outcome in 217 patients. Blood 1994; 83: 2423-2427.
6. Rosenberg UB, Schroder C, Preiss A, et al. Structural homology of the product of Drosophila Kruppel gene with Xenopus transcription factor IIIA. Nature 1989; 319: 336-339.
7. El-Baradi T, Pieler T. Zinc-finger proteins: what we know and what we would like to know. Mech Dev 1991; 35: 155-169.
8. Hockenbery D, Nunez G, Milliman C, et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-336.
9. Lo Coco F, Ye BH, Lista F, et al. Rearrangements of the Bcl-6 gene in diffuse large-cell non-Hodgkin's lymphoma Blood 1994; 83: 1757-1759.
10. Offitt K, Lo Coco F, Louie DC, et al. Rearrangement of the Bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med 1994; 331: 74-80.
11. Pescarmona E, Lo Coco F, Pacchiarotti A, et al. Analysis of the Bcl-6 gene configuration in diffuse B-cell non-Hodgkin's lymphomas and Hodgkin's disease. J Pathol 1995; 177: 21-25.
12. Weiss LM, Warnke RA, Sklar J, Cleary ML. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med 1987; 317: 1185-1189.
13. Aisenberg AC, Wilkes BM, Jacobson JO. The Bcl-2 gene is rearranged in many diffuse B-cell lymphomas. Blood 1988; 71: 969-972.
14. Jacobson JO, Wilkes BM, Kwiatkowski DJ, et al. Bcl-2 rearrangements in de novo diffuse large cell lymphoma. Association with distinctive clinical features. Cancer 1993; 72: 231-236.
15. Stansfeld AG, Diebold J, Kapanci Y, et al. Updated Kiel classification for lymphomas. Lancet 1988; i: 292-293.
16. Fritsch EF, Maniatis T, Sambrook J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1982.
17. Shipp M, Harrington D. Development of a predictive model for aggressive lymphoma: the International NHL Prognostic Factor Project. Proc Am Soc Clin Oncol 1992; 11: 919.
18. Kaplan E, Meier P. Non-parametric estimation for incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
19. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of diseases. J Natl Cancer Inst 1959; 22: 209-220.
20. Addis BJ, Isaacson PG. Large cell lymphoma of the mediastinum: a B-cell tumour of probable thymic origin. Histopathology 1986; 10: 379-390.
21. Cazals-Hatem D, Lepage E, Brice P, et al. Primary mediastinal large B-cell lymphoma. Am J Surg Pathol 1996; 20: 877-888.
22. Ramsay AD, Smith WJ, Isaacson PG. T-cell-rich B-cell lymphoma. Am J Surg, Pathol 1988; 12: 433-443.
23. Macon WR, Williams ME, Greer JP, et al. T-cell rich B-cell lymphomas. Am J Surg Pathol 1992; 16: 351-363.
24. Lennert K. The proposal for a revised European-American lymphoma classification. A new start of a transatlantic discussion. Histopathology 1995; 26: 481-483.
25. Onizuka T, Moriyama M, Yamochi T, et al. Bcl-6 gene product, a 92-to 98 kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterpart. Blood 1995; 86: 28-37.
26. Cattoretti G, Chang CC, Cechova K, et al. Bcl-6 protein is expressed in germinal center B cells. Blood 1995; 86: 45-53.
27. Flenghi L, Ye BH, Fizzotti M, et al. A specific monoclonal antibody (PG-B6) detects expression of the Bcl-6 protein in germinal center B cells. Am J Pathol 1995p; 147: 405-411.
28. Pittaluga S, Ayoubi TAY, Wlodarska I, et al. Bcl-6 expression in reactive lymphoid tissue and in B-cell non-Hodgkin's lymphomas. J Pathol 1996: 179: 145-150.
29. Nakamura Y, Miki T, Miura I, et al. Internal DNA deletion within the Bcl-6 gene on untranslocated chromosome in non-Hodgkin's lymphoma with 3q27 abnormality. Leukemia 1996; 10: 658-661.
30. Migliazza A, Martinotti S, Chen W, et al. Frequent somatic hypermutation of the 5′ noncoding region of the Bcl-6 gene in B-cell lymphoma. Proc Natl Acad Sci USA 1995; 92: 12520-12524.
31. Volpe G, Vitolo U, Carbone A, et al. Molecular heterogeneity of B-lineage diffuse large cell lymphoma. Gene, Chrom Cancer 1996; 16: 21-30.